February 28th, 2017
Schahram Akbarian, M.D., Ph.D.
Chief, Division of Epigenomics at Icahn School of Medicine at Mount Sinai
“The Human Brain And Its Epigenome”
Robert Rollins, Ph.D.
Pfizer Research & Development
Senior Principal Scientist, Oncology Therapeutics Discovery – Epigenetics
“Epigenetic Cancer Therapy: Promises and Challenges”
Krishnan Viswanadhan, Pharm.D., MBA
Celgene Corporation – Strategic Development Leader
“Development of IDH2 Inhibitor, Enasidenib in AML”